I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A phase ii trial of short course fludarabine, mitoxantrone,..:
Zinzani P. L
;
Tani M
;
Pulsoni A
...
info:eu-repo/semantics/altIdentifier/pmid/21536660. , 2012
Link:
http://hdl.handle.net/2434/724944
RT Journal T1
A phase ii trial of short course fludarabine, mitoxantrone, rituximab followed by 90y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
UL https://suche.suub.uni-bremen.de/peid=base-ftunivmilanoair:oai:air.unimi.it:2434_724944&Exemplar=1&LAN=DE A1 Zinzani P. L A1 Tani M A1 Pulsoni A A1 De Renzo A A1 Stefoni V A1 Broccoli A A1 Montini G. C A1 Fina M A1 Pellegrini C A1 Gandolfi L A1 Cavalieri E A1 Torelli F A1 Scopinaro F A1 Argnani L A1 Quirini F A1 Derenzini E A1 Rossi M A1 Pileri S A1 Fanti S A1 Baccarani M PB Oxford University Press YR 2012 K1 90 K1 Y-ibritumomab tiuxetan K1 Fludarabine K1 Follicular lymphoma K1 Mitoxantrone K1 Radioimmunotherapy K1 Rituximab K1 Adult K1 Aged K1 80 and over K1 Antibodies K1 Monoclonal K1 Murine-Derived K1 Antineoplastic Combined Chemotherapy Protocol K1 Female K1 Human K1 Induction Chemotherapy K1 Lymphoma K1 Follicular K1 Male K1 Middle Aged K1 Prospective Studie K1 Treatment Outcome K1 Vidarabine K1 Yttrium Radioisotopes K1 Settore MED/15 - Malattie del Sangue JF info:eu-repo/semantics/altIdentifier/pmid/21536660 LK http://hdl.handle.net/2434/724944 DO http://hdl.handle.net/2434/724944 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)